17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation

被引:50
|
作者
Dijkstra, M. K. [1 ]
van Lom, K. [1 ]
Tielemans, D. [2 ]
Elstrodt, F. [3 ]
Langerak, A. W. [2 ]
van't Veer, M. B. [1 ]
Jongen-Lavrencic, M. [1 ]
机构
[1] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands
[3] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands
关键词
TUMOR-SUPPRESSOR;
D O I
10.1038/leu.2008.264
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:625 / 627
页数:4
相关论文
共 50 条
  • [21] Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity
    Libe, Rossella
    Groussin, Lionel
    Tissier, Frederique
    Elie, Caroline
    Rene-Corail, Fernande
    Fratticci, Amato
    Jullian, Eric
    Beck-Peccoz, Paolo
    Bertagna, Xavier
    Gicquel, Christine
    Bertherat, Jerome
    CLINICAL CANCER RESEARCH, 2007, 13 (03) : 844 - 850
  • [22] Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas
    Clausen, OPF
    Lothe, RA
    Borresen-Dale, AL
    De Angelis, P
    Chen, Y
    Rognum, TO
    Meling, GI
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1998, 7 (04) : 215 - 223
  • [23] 17P deletion and TP53 gene mutation (17P/TP53) testing behaviour and treatment patterns for chronic lymphocytic leukemia (CLL) patients in France, Germany, Italy, Spain and UK (EU5)
    Canta, F. A. Bermudez
    Mitrofan, L.
    Karanis, Y. B.
    Mistry, H.
    Anger, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Characterization of p53 inactivation in B-CLL patients
    Trbusek, M
    Malcikova, J
    Smardova, J
    Bukovska, S
    Svitakova, M
    Mentzlova, D
    Kuglik, P
    Linkova, V
    Doubek, M
    Brychtova, Y
    Pospisilova, S
    Dvorakova, D
    Mayer, J
    ANNALS OF ONCOLOGY, 2005, 16 : 200 - 201
  • [25] The Pathogenomic Landscape of Diffuse Large B-Cell Lymphomas (DLBCL) Reveals That MYC/TP53 Coexpression and Loss of 17p13 Are Independently Associated With Inferior Survival
    Ma, Charles
    Thodima, Venkata
    Xie, Yi
    Tulpule, Anil
    Desai, Kshijita
    Sidoti, Hannah
    Caviasco, Christina
    Siddiqi, Imran
    Houldsworth, Jane
    MODERN PATHOLOGY, 2015, 28 : 361A - 362A
  • [26] miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities
    M Mraz
    K Malinova
    J Kotaskova
    S Pavlova
    B Tichy
    J Malcikova
    K Stano Kozubik
    J Smardova
    Y Brychtova
    M Doubek
    M Trbusek
    J Mayer
    S Pospisilova
    Leukemia, 2009, 23 : 1159 - 1163
  • [27] The Pathogenomic Landscape of Diffuse Large B-Cell Lymphomas (DLBCL) Reveals That MYC/TP53 Coexpression and Loss of 17p13 Are Independently Associated With Inferior Survival
    Ma, Charles
    Thodima, Venkata
    Tulpule, Anil
    Desai, Kshijita
    Sidoti, Hannah
    Caviasco, Christina
    Siddiqi, Imran
    Houldsworth, Jane
    LABORATORY INVESTIGATION, 2015, 95 : 361A - 362A
  • [28] miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities
    Mraz, M.
    Malinova, K.
    Kotaskova, J.
    Pavlova, S.
    Tichy, B.
    Malcikova, J.
    Kozubik, K. Stano
    Smardova, J.
    Brychtova, Y.
    Doubek, M.
    Trbusek, M.
    Mayer, J.
    Pospisilova, S.
    LEUKEMIA, 2009, 23 (06) : 1159 - 1163
  • [29] Allelic loss on 17p13 (TP53) and allelic loss on 3p21 in early squamous cell carcinoma of the lung
    Endo, C
    Sato, M
    Fujimura, S
    Sakurada, A
    Aikawa, H
    Takahashi, S
    Usuda, K
    Saito, Y
    Sagawa, M
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 2000, 30 (08): : 695 - 699
  • [30] Allelic loss on 17p13 (TP53) and allelic loss on 3p21 in early squamous cell carcinoma of the lung
    Chiaki Endo
    Masami Sato
    Shigefumi Fujimura
    Akira Sakurada
    Hirokazu Aikawa
    Satomi Takahashi
    Katsuo Usuda
    Yasuki Saito
    Motoyasu Sagawa
    Surgery Today, 2000, 30 : 695 - 699